Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
resourceType | ValueSet |
id | 2.16.840.1.113762.1.4.1234.49 |
canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.49 |
version | 20211123 |
status | active |
publisher | BEST System Steward |
name | InfluenzaVaccineCodesForExposureIdentification |
title | Influenza vaccine codes for exposure identification |
date | 2021-11-23T01:02:05-05:00 |
experimental | false |
Usages | (none) |
This value set contains 112 concepts
Code | System | Display |
1005911 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain |
1005931 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain |
111 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, live, attenuated, for intranasal use |
123 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) |
125 | http://hl7.org/fhir/sid/cvx | Novel Influenza-H1N1-09, live virus for nasal administration |
126 | http://hl7.org/fhir/sid/cvx | Novel influenza-H1N1-09, preservative-free, injectable |
127 | http://hl7.org/fhir/sid/cvx | Novel influenza-H1N1-09, injectable |
128 | http://hl7.org/fhir/sid/cvx | Novel influenza-H1N1-09, all formulations |
1303855 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza B virus vaccine, B-Wisconsin-1-2010-like virus |
1304122 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus |
1304278 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza B virus vaccine, B-Texas-6-2011, inactivated |
135 | http://hl7.org/fhir/sid/cvx | influenza, high dose seasonal, preservative-free |
140 | http://hl7.org/fhir/sid/cvx | Influenza, seasonal, injectable, preservative free |
141 | http://hl7.org/fhir/sid/cvx | Influenza, seasonal, injectable |
1427019 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated |
1427022 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza B virus vaccine, B-Massachusetts-2-2012-like virus |
1428984 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza B virus vaccine, B-Massachusetts-2-2012 BX-51B, inactivated |
144 | http://hl7.org/fhir/sid/cvx | seasonal influenza, intradermal, preservative free |
1442194 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza B virus vaccine, B-Massachusetts-2-2012-like virus, recombinant |
149 | http://hl7.org/fhir/sid/cvx | influenza, live, intranasal, quadrivalent |
15 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE |
150 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, quadrivalent, preservative free |
151 | http://hl7.org/fhir/sid/cvx | influenza nasal, unspecified formulation |
153 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, Madin Darby Canine Kidney, preservative free |
1541617 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus |
155 | http://hl7.org/fhir/sid/cvx | Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free |
158 | http://hl7.org/fhir/sid/cvx | influenza, injectable, quadrivalent, contains preservative |
16 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, whole virus |
160 | http://hl7.org/fhir/sid/cvx | Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 |
161 | http://hl7.org/fhir/sid/cvx | Influenza, injectable,quadrivalent, preservative free, pediatric |
166 | http://hl7.org/fhir/sid/cvx | influenza, intradermal, quadrivalent, preservative free, injectable |
168 | http://hl7.org/fhir/sid/cvx | Seasonal trivalent influenza vaccine, adjuvanted, preservative free |
171 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent |
1804259 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza A virus A/Vietnam/1203/2004 (H5N1) antigen |
185 | http://hl7.org/fhir/sid/cvx | Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free |
186 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative |
194 | http://hl7.org/fhir/sid/cvx | influenza, Southern Hemisphere, unspecified formulation |
197 | http://hl7.org/fhir/sid/cvx | influenza, high-dose seasonal, quadrivalent, 0.7mL dose, preservative free |
200 | http://hl7.org/fhir/sid/cvx | influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free |
201 | http://hl7.org/fhir/sid/cvx | influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative |
202 | http://hl7.org/fhir/sid/cvx | influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative |
205 | http://hl7.org/fhir/sid/cvx | influenza, seasonal vaccine, quadrivalent, adjuvanted, 0.5mL dose, preservative free |
2050418 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe |
2050422 | http://www.nlm.nih.gov/research/umls/rxnorm | Fluzone 2018-2019 Injectable Product |
2050423 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2018-2019] |
2050776 | http://www.nlm.nih.gov/research/umls/rxnorm | Fluzone Quadrivalent 2018-2019 Injectable Product |
2050787 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2018-2019] |
2177393 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe |
2177397 | http://www.nlm.nih.gov/research/umls/rxnorm | Fluarix Quadrivalent 2019-2020 Injectable Product |
2177398 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2019-2020] |
2177494 | http://www.nlm.nih.gov/research/umls/rxnorm | Fluzone Quadrivalent 2019-2020 Injectable Product |
2177495 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2019-2020] |
2177498 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection |
2177500 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2019-2020] |
2177503 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe |
2177504 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2019-2020] |
2177590 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension |
2177592 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2019-2020] |
2177692 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe |
2177696 | http://www.nlm.nih.gov/research/umls/rxnorm | Fluzone 2019-2020 Injectable Product |
2177697 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2019-2020] |
2177790 | http://www.nlm.nih.gov/research/umls/rxnorm | Flulaval Quadrivalent 2019-2020 |
2177793 | http://www.nlm.nih.gov/research/umls/rxnorm | Flulaval Quadrivalent 2019-2020 Injectable Product |
2177794 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Flulaval Quadrivalent 2019-2020] |
2177797 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2019-2020] |
2178091 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe |
2178093 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2019-2020] |
2178357 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe |
2178362 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2019-2020] |
2178784 | http://www.nlm.nih.gov/research/umls/rxnorm | Afluria Quadrivalent 2019-2020 Injectable Product |
2178785 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2019-2020] |
2178787 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2019-2020] |
2178789 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Afluria Quadrivalent 2019-2020] |
2180401 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe |
2180406 | http://www.nlm.nih.gov/research/umls/rxnorm | 0.5 ML influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2019-2020] |
2180409 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension |
2180411 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension [Flucelvax Quadrivalent 2019-2020] |
69 | http://hl7.org/fhir/sid/cvx | parainfluenza-3 virus vaccine |
857921 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza B virus vaccine B/Brisbane/60/2008 antigen |
864701 | http://www.nlm.nih.gov/research/umls/rxnorm | influenza A-California-7-2009-(H1N1)v-like virus vaccine |
88 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, unspecified formulation |
90630 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use |
90653 | http://www.ama-assn.org/go/cpt | Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use |
90654 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use |
90655 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use |
90656 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use |
90657 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use |
90658 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use |
90660 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use |
90661 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use |
90662 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use |
90664 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, live (LAIV), pandemic formulation, for intranasal use |
90666 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine (IIV), pandemic formulation, split virus, preservative free, for intramuscular use |
90667 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine (IIV), pandemic formulation, split virus, adjuvanted, for intramuscular use |
90668 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine (IIV), pandemic formulation, split virus, for intramuscular use |
90672 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use |
90673 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use |
90674 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use |
90682 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use |
90685 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use |
90686 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use |
90687 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use |
90688 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use |
90694 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use |
90756 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use |
G0008 | http://www.nlm.nih.gov/research/umls/hcpcs | Administration of influenza virus vaccine |
Q2034 | http://www.nlm.nih.gov/research/umls/hcpcs | Influenza virus vaccine, split virus, for intramuscular use (agriflu) |
Q2035 | http://www.nlm.nih.gov/research/umls/hcpcs | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) |
Q2036 | http://www.nlm.nih.gov/research/umls/hcpcs | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) |
Q2037 | http://www.nlm.nih.gov/research/umls/hcpcs | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
Q2038 | http://www.nlm.nih.gov/research/umls/hcpcs | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
Q2039 | http://www.nlm.nih.gov/research/umls/hcpcs | Influenza virus vaccine, not otherwise specified |
Produced 08 Sep 2023